Literature DB >> 10155609

Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study.

C Selai1, R Rosser.   

Abstract

We conducted a microstudy to elicit health state descriptions and utility values, using the EuroQol instrument, from a sample of acutely ill inpatients on 5 wards at University College London Medical School. Most current work to date has elicited such descriptive and valuation data from random surveys of the general population. One problem with this is that most responders from the general population have not actually experienced the states being valued. Our goal was to ascertain whether there were any differences between the values given by inpatients and those of the general population. However, the small sample size of patients included in our feasibility study means our conclusions must remain tentative. Nevertheless, the results suggest that patients give higher values than the general population. We suggest that more research needs to be done eliciting values from patients.

Entities:  

Mesh:

Year:  1995        PMID: 10155609     DOI: 10.2165/00019053-199508020-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  11 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

Review 2.  Methodology for measuring health-state preferences--III: Population and context effects.

Authors:  D G Froberg; R L Kane
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

3.  Health related quality of life measurement--Euro style.

Authors:  R A Carr-Hill
Journal:  Health Policy       Date:  1992       Impact factor: 2.980

4.  EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway.

Authors:  E Nord
Journal:  Health Policy       Date:  1991-06       Impact factor: 2.980

5.  Quality of life measures in health care. III: Resource allocation.

Authors:  D J Spiegelhalter; S M Gore; R Fitzpatrick; A E Fletcher; D R Jones; D R Cox
Journal:  BMJ       Date:  1992-11-14

Review 6.  Developing a model of quality of life in epilepsy: the contribution of neuropsychology.

Authors:  B P Hermann
Journal:  Epilepsia       Date:  1993       Impact factor: 5.864

7.  The utility of different health states as perceived by the general public.

Authors:  D L Sackett; G W Torrance
Journal:  J Chronic Dis       Date:  1978

8.  A scale of valuations of states of illness: is there a social consensus?

Authors:  R Rosser; P Kind
Journal:  Int J Epidemiol       Date:  1978-12       Impact factor: 7.196

9.  Over-reporting of maladjustment by depressed subjects. Findings from retesting after recovery.

Authors:  A Morgado; N Raoux; G Jourdain; Y Lecrubier; D Widlöcher
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1991-03       Impact factor: 4.328

10.  Severely mobility-disabled people assess the quality of their lives.

Authors:  R Stensman
Journal:  Scand J Rehabil Med       Date:  1985
View more
  16 in total

1.  Valuation of EuroQOL (EQ-5D) health states in an adult US sample.

Authors:  J A Johnson; S J Coons; A Ergo; G Szava-Kovats
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

2.  The influence of ill-health experience on the valuation of health.

Authors:  X Badia; M Herdman; P Kind
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

3.  The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; Becky Tsui; G Jonathan Lewis; Robert R Muder; Lee H Harrison; Lee M Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

4.  Screening cardiac surgery patients for MRSA: an economic computer model.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; G Jonathan Lewis; Becky Y K Tsui; Kenneth J Smith; Robert R Muder
Journal:  Am J Manag Care       Date:  2010-07-01       Impact factor: 2.229

5.  Quality-of-life valuations of advanced breast cancer by New Zealand women.

Authors:  Richard J Milne; Kathy H Heaton-Brown; Paul Hansen; David Thomas; Vernon Harvey; Alison Cubitt
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  The potential economic value of a Staphylococcus aureus vaccine for neonates.

Authors:  Bruce Y Lee; Paul J Ufberg; Rachel R Bailey; Ann E Wiringa; Kenneth J Smith; Andrew J Nowalk; Conor Higgins; Angela R Wateska; Robert R Muder
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

7.  Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.

Authors:  L Lapointe-Shaw; T Voruganti; P Kohler; H-H Thein; B Sander; A McGeer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-11       Impact factor: 3.267

8.  A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients.

Authors:  C J Clancy; S M Bartsch; M H Nguyen; D R Stuckey; R K Shields; B Y Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-07       Impact factor: 3.267

9.  The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.

Authors:  Yeohan Song; Julie H Y Tai; Sarah M Bartsch; Richard K Zimmerman; Robert R Muder; Bruce Y Lee
Journal:  Vaccine       Date:  2012-03-29       Impact factor: 3.641

10.  Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?

Authors:  Bruce Y Lee; Becky Y Tsui; Rachel R Bailey; Kenneth J Smith; Robert R Muder; G Jonathan Lewis; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.